Key Highlights
- Shares are trading down about 19.63% today, on Volume far above average.
- Existing holders priced an 8 million share secondary offering at $14.50 per share.
- The price is well below Tuesday's $17.75 close.
- The company will concurrently repurchase 1.5 million shares from the underwriters.
- The offering is expected to close on November 19.
Ardent Health (NYSE:ARDT) shares are trading sharply lower today after affiliates of two existing stockholders priced a secondary public offering of 8 million shares at $14.50 per share, below Tuesday's $17.75 close. Ardent Health is a leading provider of healthcare in growing mid-sized urban communities, delivering care through a network of 30 acute care hospitals and more than 280 sites of care across six states.
Selling Stockholders Price Offering Below Prior Close
The offering consists of shares from affiliates of two existing investors, with underwriters granted a 30-day option to purchase up to an additional 1.2 million shares. The company is not selling any shares in the offering and will not receive proceeds from the sale by the selling stockholders.
Company to Repurchase 1.5 Million Shares From Underwriters
Subject to completion of the offering, the company will concurrently repurchase 1.5 million shares from the underwriters, funded from existing cash on hand, at the same price paid to the selling stockholders. The repurchase is separate from the company's previously disclosed buyback plan and will not reduce capacity under that existing authorization.
Selloff Appears Company-Specific Rather Than Sector-Driven
Shares are trading just below the offering price on volume far above average, while the broader healthcare sector ETF was little changed, suggesting today's pressure is tied specifically to the dilutive nature of the offering rather than a sector-wide move. The decline follows a recent price-target increase from one research firm and a previously announced hospital acquisition.
What Comes Next as the Offering Closes
With the offering expected to close November 19, investors are likely to watch for confirmation of final settlement and whether the underwriters exercise their option to purchase additional shares.






Please wait processing your request...